Xencor (XNCR) Goodwill & Intangibles (2013 - 2026)
Xencor (XNCR) reported Goodwill & Intangibles of $7.6 million for Q1 2026, down 43.11% year-over-year from $13.4 million in Q1 2025, and down 9.34% quarter-over-quarter from $8.4 million in Q4 2025.
Xencor (XNCR) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Goodwill & Intangibles data on file, last reported at $7.6 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $7.6 million, down 43.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 million (down 43.11% YoY), and the FY2025 annual result was $8.4 million, down 54.64% from the prior year.
- Goodwill & Intangibles fell to $7.6 million in Q1 2026 per XNCR's latest filing, from $8.4 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $18.9 million in Q1 2024 and troughed at $7.6 million in Q1 2026.
- A 5-year average of $15.9 million and a median of $18.1 million in 2022 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles climbed 12.17% in 2022, then sank 54.64% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $18.5 million in 2022, then advanced by 0.88% to $18.7 million in 2023, then fell by 0.95% to $18.5 million in 2024, then slumped by 54.64% to $8.4 million in 2025, then retreated by 9.34% to $7.6 million in 2026.
- Business Quant data shows XNCR's Goodwill & Intangibles at $7.6 million in Q1 2026, $8.4 million in Q4 2025, and $9.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.60 Mn |
| Dec 31, 2025 | 8.39 Mn |
| Sep 30, 2025 | 9.47 Mn |
| Jun 30, 2025 | 11.25 Mn |
| Mar 31, 2025 | 13.36 Mn |
| Dec 31, 2024 | 18.49 Mn |
| Sep 30, 2024 | 17.92 Mn |
| Jun 30, 2024 | 18.78 Mn |
| Mar 31, 2024 | 18.85 Mn |
| Dec 31, 2023 | 18.66 Mn |
| Sep 30, 2023 | 18.74 Mn |
| Jun 30, 2023 | 18.71 Mn |
| Mar 31, 2023 | 18.24 Mn |
| Dec 31, 2022 | 18.50 Mn |
| Sep 30, 2022 | 18.09 Mn |
| Jun 30, 2022 | 17.94 Mn |
| Mar 31, 2022 | 16.71 Mn |
| Dec 31, 2021 | 16.49 Mn |
| Sep 30, 2021 | 16.68 Mn |
| Jun 30, 2021 | 16.38 Mn |